Ridgeback Capital Investments L.P.

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer % of Class Filed
Replimune Group, Inc. 13G/A
REPL · 76029N106
 8.7%
Checked 5% or less
 8/14/2026
Event 6/30/2026
Lenz Therapeutics, Inc. 13G/A
LENZ · 52635N103
 0% 2/17/2026
Event 12/31/2025
Semler Scientific, Inc. 13G/A
SMLR · 81684M104
 0% 11/14/2025
Event 9/30/2025
iTeos Therapeutics, Inc. 13G/A
ITOS · 46565G104
 0% 11/14/2025
Event 9/30/2025
Affimed N.V. 13G/A
AFMDQ · N01045207
 0% 5/20/2025
Event 5/16/2025
Pyxis Oncology, Inc. 13G/A
PYXS · 747324101
 0.6% 2/14/2025
Event 12/31/2024